FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

MDA IN OHIO

University of Cincinnati Medical Center

  • Address:
    University Of Cincinnati Medical Center
    222 Piedmont Avenue
    Suite 3200
    Cincinnati, OH 45219
    See map: Google Maps

Location